OBJECTIVE: To test whether an inhibitor bar attached to an ankle-foot orthosis (AFO) improves walking ability in hemiplegic stroke patients with tonic toe flexion reflex (TTFR). DESIGN: Before-after trial. SETTING:Rehabilitation hospital in Japan. PARTICIPANTS: Nine patients with TTFR were assigned to the TTFR group, and 8 patients without TTFR were assigned to the control group. INTERVENTION: Inhibitor bar attached to an AFO. MAIN OUTCOME MEASURE: Gait was analyzed by measuring the number of steps and the time required to walk 10m at a maximal walking speed. RESULTS: In the TTFR group, use of an inhibitor bar for 2 weeks significantly increased the maximal walking speed, stride length, and cadence by 13.8% (P=.0045), 8.0% (P=.0398), and 6.1% (P=.0056), respectively. There were no significant changes in the control group. CONCLUSION: An inhibitor bar improved walking ability of hemiplegic patients with TTFR, and its use with an AFO is recommended.
RCT Entities:
OBJECTIVE: To test whether an inhibitor bar attached to an ankle-foot orthosis (AFO) improves walking ability in hemiplegic strokepatients with tonic toe flexion reflex (TTFR). DESIGN: Before-after trial. SETTING: Rehabilitation hospital in Japan. PARTICIPANTS: Nine patients with TTFR were assigned to the TTFR group, and 8 patients without TTFR were assigned to the control group. INTERVENTION: Inhibitor bar attached to an AFO. MAIN OUTCOME MEASURE: Gait was analyzed by measuring the number of steps and the time required to walk 10m at a maximal walking speed. RESULTS: In the TTFR group, use of an inhibitor bar for 2 weeks significantly increased the maximal walking speed, stride length, and cadence by 13.8% (P=.0045), 8.0% (P=.0398), and 6.1% (P=.0056), respectively. There were no significant changes in the control group. CONCLUSION: An inhibitor bar improved walking ability of hemiplegic patients with TTFR, and its use with an AFO is recommended.